Medtronic links renal denervation to 3-year blood pressure reduction

Patients treated with Symplicity Spyral had significantly lower blood pressure than people who received a sham treatment after three years.

Corcym, CardioPrecision set sights on robotic heart valve replacement

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the longer-term advantages of open heart surgery.

Health systems are racing to adopt AI. But can they prove its value?

Measuring financial returns from AI can be challenging, experts said at the HLTH conference last week. But other metrics, like provider and patient satisfaction, are important too — and also impact providers’ bottom lines.

J&J awards first grants from AI surgery fund

Mayo Clinic and QAS.AI will receive funding and mentorship to help advance their projects.

CMS calls back furloughed employees to help with Medicare, ACA enrollment periods

Roughly 3,000 employees are coming back to work on Monday, funded by user fees as the shutdown drags into its fourth week.

Medtech industry closely watching Section 232 investigation

The investigation, which could be used to impose tariffs for medical products, has raised the attention of several industry groups. Check out MedTech Dive’s roundup of coverage on the 232 probe.

Accuray hires Steve La Neve as CEO in transformation effort

The radiotherapy systems maker unveiled the leadership change and strategy initiatives as it reported a preliminary fiscal first-quarter adjusted loss.